Adagio CEO Gerngross to exit Covid antibody company he founded

Adagio Therapeutics Inc. CEO Tillman Gerngross is stepping away from the startup he founded as the drugmaker works to determine just how effective its Covid-19 antibodies are against the omicron variant of the coronavirus.